Admission hyperglycemia and TIMI frame count in primary percutaneous coronary intervention
Angiology, cilt.63, sa.5, ss.325-329, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 63 Sayı: 5
- Basım Tarihi: 2012
- Doi Numarası: 10.1177/0003319711418957
- Dergi Adı: Angiology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.325-329
- Anahtar Kelimeler: coronary flow, blood glucose, ST-segment elevation myocardial infarction
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
We evaluated the relationship between admission blood glucose levels and estimated coronary flow by the thrombolysis in myocardial infarction (TIMI) frame count (TFC) method in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). The TFC of 121 consecutive patients with STEMI were evaluated after pPCI. Patients with admission glucose levels >198 mg/dL (11 mmol/L) were defined as hyperglycemic. Hyperglycemia was observed in 36 (29.8%) patients. The TFC was significantly higher in patients with hyperglycemia (70.75 [10-96] vs 56.87 [8-100], P =.04). No-reflow frequency was higher in the hyperglycemia group (44.4% vs 23.5%, P =.02). In multivariate linear regression analysis admission glucose was an independent predictor of high TFC (B = 0.21, P =.02). Our findings suggest that admission blood glucose is a predictor of TFC which reflects coronary blood flow. © 2012 The Author(s).